Farmacias Competitors

Stocks . Mexico . 
Stock . Farmacias Benavides SAB
BEVIDESB  MXN 22.00  1.00  4.76%   
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Farmacias Benavides' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
19.6222.0024.38
Details
Intrinsic
Valuation
LowRealHigh
16.8319.2124.20
Details
Naive
Forecast
LowNextHigh
20.3722.7525.13
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
8.8220.5332.24
Details

Farmacias Benavides Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Farmacias Benavides and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Farmacias and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Farmacias Benavides SAB does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
V
+ 0.94
MA
NVDA
+ 0.76
MA
LLY
+ 0.71
ENPH
V
+ 0.7
NVDA
FGEN
+ 0.19
V
VALUEGFO
+ 0.14
ENPH
  
High negative correlations   
MA
- 0.91
ENPH
V
- 0.89
ENPH
NVDA
- 0.86
ENPH
LLY
- 0.76
V
LLY
- 0.65
MA
LLY
- 0.42
NVDA

Risk-Adjusted Indicators

There is a big difference between Farmacias Stock performing well and Farmacias Benavides Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Farmacias Benavides' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Farmacias Benavides Competitive Analysis

The better you understand Farmacias Benavides competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Farmacias Benavides' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Farmacias Benavides' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BEVIDESB ENPH VALUEGFO PUKN MA NVDA V LLY FGEN
 4.76 
 22.00 
Farmacias
 3.47 
 1,490 
Enphase
 0.00 
 93.04 
Value
 0.00 
 439.00 
Prudential
 0.56 
 10,581 
Mastercard
 0.21 
 2,822 
NVIDIA
 0.34 
 6,430 
Visa
 0.04 
 16,063 
Eli
 26.74 
 10.19 
FibroGen
Market Volatility
(90 Days Market Risk)
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Moderately volatile
Market Performance
(90 Days Performance)
Modest
Very Weak
Very Weak
Very Weak
OK
OK
Solid
Very Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Below Average
Low
Low
Low
Low
Low
Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Hold
Strong Hold
Strong Hold
Strong Sell
Cautious Hold
Strong Sell
Current Ratio
1.08
5.2
0.51
1.02
1.4
5.8
2.0
1.12
6.16
Net Asset
6.88 B
N/A
20.05 B
199.1 B
38.72 B
44.19 B
85.5 B
48.81 B
773.82 M
Profit Margin
0.0036
11.11
N/A
1.11
0.45
0.21
0.5
0.22
-2.94
EBITDA
1.43 B
223.59 M
N/A
1.86 B
12.95 B
11.35 B
19.54 B
8.28 B
(288.53 M)
Operating Margin
0.0458
23.68
9.07
0.97
0.57
0.26
0.67
0.29
-2.52
Current Valuation
6.36 B
934.5 B
24.96 B
705.01 B
6.85 T
8.18 T
8.91 T
6.99 T
21.87 B
Price To Book
20.47
852.64
5.12
1.88
53.37
19.7
12.72
34.76
54.45
Retained Earnings
N/A
N/A
N/A
10.44 B
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
N/A
23.7 B
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
N/A
2.49
0.57
0.28
0.6
2.46
N/A
Beta
-0.02
1.15
0.41
1.35
1.08
1.79
0.96
0.35
0.85
Number Of Employees
7.49 K
850
24
40
55
22.47 K
26.5 K
47
566
Shares Outstanding
358.84 M
135.7 M
160 M
1.37 B
948 M
2.46 B
1.62 B
950.18 M
93.96 M
Cash Flow From Operations
1.2 B
252.95 M
578 M
(145 M)
11.2 B
9.11 B
18.85 B
7.26 B
(82.23 M)
Annual Yield
N/A
N/A
N/A
0.0162
0.0062
8.0E-4
0.008
0.0138
N/A
Total Debt
1.25 B
1.02 B
11.82 B
6.14 B
13.75 B
10.95 B
20.2 B
15.35 B
77.14 M
Return On Equity
0.92
18.45
-0.21
0.0769
1.44
0.26
0.42
0.65
-1.85
Z Score
3.2
N/A
0.6
78.0
N/A
N/A
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
N/A
N/A
N/A
5.0
N/A
N/A
Return On Asset
0.0629
7.99
-0.0684
0.0033
0.21
0.11
0.15
0.11
-0.27
Book Value Per Share
0.21
5.4
37.83
11.77
6.59
8.65
16.98
11.19
0.28
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
1
N/A
N/A
Current Liabilities
N/A
N/A
N/A
19.7 B
N/A
N/A
N/A
N/A
N/A
Total Asset
6.88 B
N/A
20.05 B
199.1 B
38.72 B
44.19 B
85.5 B
48.81 B
773.82 M
Debt To Equity
301.7
1.39
222.2
0.47
127.4
0.6
0.56
648.2
15.1
Target Price
N/A
N/A
95.77
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
0.18
2.04
0.16
1.65
3.92
N/A
Shares Owned By Institutions
N/A
69.99
N/A
1.95
79.04
67.14
99.05
85.0
78.8
Market Capitalization
3.24 B
638.46 B
20.26 B
800.2 B
6.52 T
10.4 T
8.96 T
6.16 T
43.36 B
Price To Earning
N/A
335.84
14.52
23.14
885.23
25.83
44.69
333.06
N/A
Price To Earnings To Growth
N/A
N/A
N/A
0.58
1.32
4.06
1.63
2.23
N/A
Price To Sales
0.21
733.32
497.32
386.39
300.73
290.21
285.84
231.96
231.63
Net Income
9.71 M
96.76 M
611 M
(2.04 B)
9.93 B
9.75 B
14.96 B
6.24 B
(290.02 M)
Earnings Per Share
0.02
13.71
0.44
17.4
192.02
44.15
134.53
123.49
-62.14
Shares Owned By Insiders
95.6
6.26
40.5
N/A
10.87
4.21
0.14
0.15
7.82
Revenue
14.74 B
870.63 M
2.18 B
26.5 B
22.24 B
26.91 B
29.31 B
28.54 B
235.31 M
Year To Date Return
N/A
N/A
N/A
N/A
N/A
N/A
0.58
N/A
N/A
Working Capital
N/A
N/A
N/A
4.01 B
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
366.78 M
1.49 B
295.04 M
6.3 B
7.17 B
19.65 B
19.24 B
2.2 B
565.4 M
Cash Per Share
0.9
5.49
1.84
4.83
7.02
7.86
9.05
2.39
6.56
Gross Profit
4.55 B
345.98 M
160 M
6 B
22.24 B
17.48 B
28.57 B
21.91 B
(104.61 M)
Day Typical Price
22.0
1490.01
93.04
439.0
10581.26
2823.61
6427.67
16062.67
10.11
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
0.0227
0.0011
1.0E-4
0.0819
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
64.98
7.0
1.0
0.86
Daily Balance Of Power
9.2 T
9.2 T
0.0
0.0
(9,223,372,036,855)
0.0896
3.071429
5.95
2.5
Period Momentum Indicator
1.0
50.0
N/A
N/A
(59.82)
5.82
21.5
5.95
2.15
Rate Of Daily Change
1.05
1.03
1.0
1.0
0.99
1.0
1.0
1.0
1.27
Day Median Price
22.0
1490.01
93.04
439.0
10581.26
2824.54
6426.5
16062.5
10.07
Price Action Indicator
0.5
25.0
N/A
N/A
(29.91)
0.13
14.25
3.48
1.19
Relative Strength Index
76.26
36.19
56.17
N/A
53.69
45.76
62.69
41.57
35.55
Coefficient Of Variation
1340.8
(769.74)
40794.55
N/A
809.17
667.91
575.84
(2,028)
1212.74
Mean Deviation
0.7134
2.88
0.8108
N/A
0.998
1.83
0.9926
1.61
2.99
Jensen Alpha
0.1668
(0.57)
0.0053
N/A
0.1503
0.3313
0.2418
(0.15)
0.4749
Total Risk Alpha
0.0612
(0.73)
(0.13)
N/A
0.097
0.239
0.1776
(0.23)
0.2322
Sortino Ratio
N/A
N/A
(0.01)
N/A
0.0949
0.1296
0.1543
N/A
0.0487
Downside Variance
N/A
N/A
23.91
N/A
1.61
5.58
1.77
N/A
91.82
Standard Deviation
2.29
4.14
2.86
N/A
1.34
2.34
1.44
2.42
6.21
Kurtosis
22.89
3.69
16.9
N/A
0.5551
(0.40)
5.08
2.27
6.29
Potential Upside
3.09
5.44
N/A
N/A
1.89
4.12
2.98
4.12
12.62
Treynor Ratio
(0.89)
(0.84)
0.0126
N/A
1.14
1.26
(5.12)
(0.21)
0.6496
Maximum Drawdown
12.46
20.14
19.54
N/A
6.13
9.71
7.05
12.41
33.83
Variance
5.23
17.13
8.17
N/A
1.78
5.49
2.08
5.85
38.52
Market Risk Adjusted Performance
(0.88)
(0.83)
0.0226
N/A
1.15
1.27
(5.11)
(0.20)
0.6596
Risk Adjusted Performance
0.0661
(0.1)
0.0092
N/A
0.1028
0.1263
0.1433
(0.03)
0.0746
Skewness
(0.50)
(1.28)
2.56
N/A
0.1205
(0.1)
(0.25)
0.4229
1.24
Semi Deviation
N/A
N/A
1.63
N/A
1.04
2.12
1.06
N/A
3.77
Information Ratio
0.055
(0.14)
(0.01)
N/A
0.0901
0.1306
0.1426
(0.07)
0.0753
Value At Risk
N/A
(6.16)
(2.53)
N/A
(2.16)
(3.57)
(1.22)
(4.46)
(10.45)
Expected Short fall
N/A
N/A
(13.39)
N/A
(1.26)
(1.93)
(1.20)
N/A
(11.48)
Downside Deviation
N/A
N/A
4.89
N/A
1.27
2.36
1.33
N/A
9.58
Semi Variance
N/A
N/A
2.65
N/A
1.08
4.48
1.12
N/A
14.24

Farmacias Benavides Competition Performance Charts

Five steps to successful analysis of Farmacias Benavides Competition

Farmacias Benavides' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Farmacias Benavides SAB in relation to its competition. Farmacias Benavides' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Farmacias Benavides in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Farmacias Benavides' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Farmacias Benavides SAB, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Farmacias Benavides position

In addition to having Farmacias Benavides in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Marijuana Thematic Idea Now

Marijuana
Marijuana Theme
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Farmacias Stock Analysis

When running Farmacias Benavides' price analysis, check to measure Farmacias Benavides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Farmacias Benavides is operating at the current time. Most of Farmacias Benavides' value examination focuses on studying past and present price action to predict the probability of Farmacias Benavides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Farmacias Benavides' price. Additionally, you may evaluate how the addition of Farmacias Benavides to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY